Global Vaginosis Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vaginosis Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vaginosis Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vaginosis Drug by Country/Region, 2017, 2022 & 2028

2.2 Vaginosis Drug Segment by Type

2.2.1 Rx

2.2.2 OTC

2.3 Vaginosis Drug Sales by Type

2.3.1 Global Vaginosis Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Vaginosis Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vaginosis Drug Sale Price by Type (2017-2022)

2.4 Vaginosis Drug Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Other

2.5 Vaginosis Drug Sales by Application

2.5.1 Global Vaginosis Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Vaginosis Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vaginosis Drug Sale Price by Application (2017-2022)

3 Global Vaginosis Drug by Company

3.1 Global Vaginosis Drug Breakdown Data by Company

3.1.1 Global Vaginosis Drug Annual Sales by Company (2020-2022)

3.1.2 Global Vaginosis Drug Sales Market Share by Company (2020-2022)

3.2 Global Vaginosis Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Vaginosis Drug Revenue by Company (2020-2022)

3.2.2 Global Vaginosis Drug Revenue Market Share by Company (2020-2022)

3.3 Global Vaginosis Drug Sale Price by Company

3.4 Key Manufacturers Vaginosis Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vaginosis Drug Product Location Distribution

3.4.2 Players Vaginosis Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vaginosis Drug by Geographic Region

4.1 World Historic Vaginosis Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Vaginosis Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vaginosis Drug Annual Revenue by Geographic Region

4.2 World Historic Vaginosis Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Vaginosis Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vaginosis Drug Annual Revenue by Country/Region

4.3 Americas Vaginosis Drug Sales Growth

4.4 APAC Vaginosis Drug Sales Growth

4.5 Europe Vaginosis Drug Sales Growth

4.6 Middle East & Africa Vaginosis Drug Sales Growth

5 Americas

5.1 Americas Vaginosis Drug Sales by Country

5.1.1 Americas Vaginosis Drug Sales by Country (2017-2022)

5.1.2 Americas Vaginosis Drug Revenue by Country (2017-2022)

5.2 Americas Vaginosis Drug Sales by Type

5.3 Americas Vaginosis Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vaginosis Drug Sales by Region

6.1.1 APAC Vaginosis Drug Sales by Region (2017-2022)

6.1.2 APAC Vaginosis Drug Revenue by Region (2017-2022)

6.2 APAC Vaginosis Drug Sales by Type

6.3 APAC Vaginosis Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vaginosis Drug by Country

7.1.1 Europe Vaginosis Drug Sales by Country (2017-2022)

7.1.2 Europe Vaginosis Drug Revenue by Country (2017-2022)

7.2 Europe Vaginosis Drug Sales by Type

7.3 Europe Vaginosis Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vaginosis Drug by Country

8.1.1 Middle East & Africa Vaginosis Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vaginosis Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Vaginosis Drug Sales by Type

8.3 Middle East & Africa Vaginosis Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vaginosis Drug

10.3 Manufacturing Process Analysis of Vaginosis Drug

10.4 Industry Chain Structure of Vaginosis Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vaginosis Drug Distributors

11.3 Vaginosis Drug Customer

12 World Forecast Review for Vaginosis Drug by Geographic Region

12.1 Global Vaginosis Drug Market Size Forecast by Region

12.1.1 Global Vaginosis Drug Forecast by Region (2023-2028)

12.1.2 Global Vaginosis Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vaginosis Drug Forecast by Type

12.7 Global Vaginosis Drug Forecast by Application

13 Key Players Analysis

13.1 Bayer

13.1.1 Bayer Company Information

13.1.2 Bayer Vaginosis Drug Product Offered

13.1.3 Bayer Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Main Business Overview

13.1.5 Bayer Latest Developments

13.2 Pfizer

13.2.1 Pfizer Company Information

13.2.2 Pfizer Vaginosis Drug Product Offered

13.2.3 Pfizer Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Pfizer Main Business Overview

13.2.5 Pfizer Latest Developments

13.3 Sanofi

13.3.1 Sanofi Company Information

13.3.2 Sanofi Vaginosis Drug Product Offered

13.3.3 Sanofi Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Main Business Overview

13.3.5 Sanofi Latest Developments

13.4 Piramal

13.4.1 Piramal Company Information

13.4.2 Piramal Vaginosis Drug Product Offered

13.4.3 Piramal Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Piramal Main Business Overview

13.4.5 Piramal Latest Developments

13.5 Abbott

13.5.1 Abbott Company Information

13.5.2 Abbott Vaginosis Drug Product Offered

13.5.3 Abbott Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Abbott Main Business Overview

13.5.5 Abbott Latest Developments

13.6 Galderma

13.6.1 Galderma Company Information

13.6.2 Galderma Vaginosis Drug Product Offered

13.6.3 Galderma Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Galderma Main Business Overview

13.6.5 Galderma Latest Developments

13.7 Mission

13.7.1 Mission Company Information

13.7.2 Mission Vaginosis Drug Product Offered

13.7.3 Mission Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mission Main Business Overview

13.7.5 Mission Latest Developments

13.8 Alkem

13.8.1 Alkem Company Information

13.8.2 Alkem Vaginosis Drug Product Offered

13.8.3 Alkem Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Alkem Main Business Overview

13.8.5 Alkem Latest Developments

13.9 Xiuzheng

13.9.1 Xiuzheng Company Information

13.9.2 Xiuzheng Vaginosis Drug Product Offered

13.9.3 Xiuzheng Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Xiuzheng Main Business Overview

13.9.5 Xiuzheng Latest Developments

13.10 Teva

13.10.1 Teva Company Information

13.10.2 Teva Vaginosis Drug Product Offered

13.10.3 Teva Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Main Business Overview

13.10.5 Teva Latest Developments

13.11 Perrigo

13.11.1 Perrigo Company Information

13.11.2 Perrigo Vaginosis Drug Product Offered

13.11.3 Perrigo Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Perrigo Main Business Overview

13.11.5 Perrigo Latest Developments

13.12 West-Ward

13.12.1 West-Ward Company Information

13.12.2 West-Ward Vaginosis Drug Product Offered

13.12.3 West-Ward Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 West-Ward Main Business Overview

13.12.5 West-Ward Latest Developments

13.13 HPGC

13.13.1 HPGC Company Information

13.13.2 HPGC Vaginosis Drug Product Offered

13.13.3 HPGC Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 HPGC Main Business Overview

13.13.5 HPGC Latest Developments

13.14 Yunnan Baiyao

13.14.1 Yunnan Baiyao Company Information

13.14.2 Yunnan Baiyao Vaginosis Drug Product Offered

13.14.3 Yunnan Baiyao Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Yunnan Baiyao Main Business Overview

13.14.5 Yunnan Baiyao Latest Developments

13.15 Starpharma

13.15.1 Starpharma Company Information

13.15.2 Starpharma Vaginosis Drug Product Offered

13.15.3 Starpharma Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Starpharma Main Business Overview

13.15.5 Starpharma Latest Developments

13.16 Novel

13.16.1 Novel Company Information

13.16.2 Novel Vaginosis Drug Product Offered

13.16.3 Novel Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Novel Main Business Overview

13.16.5 Novel Latest Developments

13.17 Edenvridge

13.17.1 Edenvridge Company Information

13.17.2 Edenvridge Vaginosis Drug Product Offered

13.17.3 Edenvridge Vaginosis Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Edenvridge Main Business Overview

13.17.5 Edenvridge Latest Developments

14 Research Findings and Conclusion

Table 1. Vaginosis Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vaginosis Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Rx

Table 4. Major Players of OTC

Table 5. Global Vaginosis Drug Sales by Type (2017-2022) & (K Doses)

Table 6. Global Vaginosis Drug Sales Market Share by Type (2017-2022)

Table 7. Global Vaginosis Drug Revenue by Type (2017-2022) & ($ million)

Table 8. Global Vaginosis Drug Revenue Market Share by Type (2017-2022)

Table 9. Global Vaginosis Drug Sale Price by Type (2017-2022) & (USD/Dose)

Table 10. Global Vaginosis Drug Sales by Application (2017-2022) & (K Doses)

Table 11. Global Vaginosis Drug Sales Market Share by Application (2017-2022)

Table 12. Global Vaginosis Drug Revenue by Application (2017-2022)

Table 13. Global Vaginosis Drug Revenue Market Share by Application (2017-2022)

Table 14. Global Vaginosis Drug Sale Price by Application (2017-2022) & (USD/Dose)

Table 15. Global Vaginosis Drug Sales by Company (2020-2022) & (K Doses)

Table 16. Global Vaginosis Drug Sales Market Share by Company (2020-2022)

Table 17. Global Vaginosis Drug Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Vaginosis Drug Revenue Market Share by Company (2020-2022)

Table 19. Global Vaginosis Drug Sale Price by Company (2020-2022) & (USD/Dose)

Table 20. Key Manufacturers Vaginosis Drug Producing Area Distribution and Sales Area

Table 21. Players Vaginosis Drug Products Offered

Table 22. Vaginosis Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Vaginosis Drug Sales by Geographic Region (2017-2022) & (K Doses)

Table 26. Global Vaginosis Drug Sales Market Share Geographic Region (2017-2022)

Table 27. Global Vaginosis Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Vaginosis Drug Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Vaginosis Drug Sales by Country/Region (2017-2022) & (K Doses)

Table 30. Global Vaginosis Drug Sales Market Share by Country/Region (2017-2022)

Table 31. Global Vaginosis Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Vaginosis Drug Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Vaginosis Drug Sales by Country (2017-2022) & (K Doses)

Table 34. Americas Vaginosis Drug Sales Market Share by Country (2017-2022)

Table 35. Americas Vaginosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Vaginosis Drug Revenue Market Share by Country (2017-2022)

Table 37. Americas Vaginosis Drug Sales by Type (2017-2022) & (K Doses)

Table 38. Americas Vaginosis Drug Sales Market Share by Type (2017-2022)

Table 39. Americas Vaginosis Drug Sales by Application (2017-2022) & (K Doses)

Table 40. Americas Vaginosis Drug Sales Market Share by Application (2017-2022)

Table 41. APAC Vaginosis Drug Sales by Region (2017-2022) & (K Doses)

Table 42. APAC Vaginosis Drug Sales Market Share by Region (2017-2022)

Table 43. APAC Vaginosis Drug Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Vaginosis Drug Revenue Market Share by Region (2017-2022)

Table 45. APAC Vaginosis Drug Sales by Type (2017-2022) & (K Doses)

Table 46. APAC Vaginosis Drug Sales Market Share by Type (2017-2022)

Table 47. APAC Vaginosis Drug Sales by Application (2017-2022) & (K Doses)

Table 48. APAC Vaginosis Drug Sales Market Share by Application (2017-2022)

Table 49. Europe Vaginosis Drug Sales by Country (2017-2022) & (K Doses)

Table 50. Europe Vaginosis Drug Sales Market Share by Country (2017-2022)

Table 51. Europe Vaginosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Vaginosis Drug Revenue Market Share by Country (2017-2022)

Table 53. Europe Vaginosis Drug Sales by Type (2017-2022) & (K Doses)

Table 54. Europe Vaginosis Drug Sales Market Share by Type (2017-2022)

Table 55. Europe Vaginosis Drug Sales by Application (2017-2022) & (K Doses)

Table 56. Europe Vaginosis Drug Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Vaginosis Drug Sales by Country (2017-2022) & (K Doses)

Table 58. Middle East & Africa Vaginosis Drug Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Vaginosis Drug Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Vaginosis Drug Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vaginosis Drug Sales by Type (2017-2022) & (K Doses)

Table 62. Middle East & Africa Vaginosis Drug Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Vaginosis Drug Sales by Application (2017-2022) & (K Doses)

Table 64. Middle East & Africa Vaginosis Drug Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Vaginosis Drug

Table 66. Key Market Challenges & Risks of Vaginosis Drug

Table 67. Key Industry Trends of Vaginosis Drug

Table 68. Vaginosis Drug Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Vaginosis Drug Distributors List

Table 71. Vaginosis Drug Customer List

Table 72. Global Vaginosis Drug Sales Forecast by Region (2023-2028) & (K Doses)

Table 73. Global Vaginosis Drug Sales Market Forecast by Region

Table 74. Global Vaginosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Vaginosis Drug Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Vaginosis Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 77. Americas Vaginosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Vaginosis Drug Sales Forecast by Region (2023-2028) & (K Doses)

Table 79. APAC Vaginosis Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Vaginosis Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 81. Europe Vaginosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Vaginosis Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Middle East & Africa Vaginosis Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Vaginosis Drug Sales Forecast by Type (2023-2028) & (K Doses)

Table 85. Global Vaginosis Drug Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Vaginosis Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Vaginosis Drug Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Vaginosis Drug Sales Forecast by Application (2023-2028) & (K Doses)

Table 89. Global Vaginosis Drug Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Vaginosis Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Vaginosis Drug Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bayer Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 93. Bayer Vaginosis Drug Product Offered

Table 94. Bayer Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 95. Bayer Main Business

Table 96. Bayer Latest Developments

Table 97. Pfizer Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 98. Pfizer Vaginosis Drug Product Offered

Table 99. Pfizer Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 100. Pfizer Main Business

Table 101. Pfizer Latest Developments

Table 102. Sanofi Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Vaginosis Drug Product Offered

Table 104. Sanofi Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 105. Sanofi Main Business

Table 106. Sanofi Latest Developments

Table 107. Piramal Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 108. Piramal Vaginosis Drug Product Offered

Table 109. Piramal Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 110. Piramal Main Business

Table 111. Piramal Latest Developments

Table 112. Abbott Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 113. Abbott Vaginosis Drug Product Offered

Table 114. Abbott Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 115. Abbott Main Business

Table 116. Abbott Latest Developments

Table 117. Galderma Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 118. Galderma Vaginosis Drug Product Offered

Table 119. Galderma Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 120. Galderma Main Business

Table 121. Galderma Latest Developments

Table 122. Mission Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 123. Mission Vaginosis Drug Product Offered

Table 124. Mission Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 125. Mission Main Business

Table 126. Mission Latest Developments

Table 127. Alkem Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 128. Alkem Vaginosis Drug Product Offered

Table 129. Alkem Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 130. Alkem Main Business

Table 131. Alkem Latest Developments

Table 132. Xiuzheng Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 133. Xiuzheng Vaginosis Drug Product Offered

Table 134. Xiuzheng Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 135. Xiuzheng Main Business

Table 136. Xiuzheng Latest Developments

Table 137. Teva Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 138. Teva Vaginosis Drug Product Offered

Table 139. Teva Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 140. Teva Main Business

Table 141. Teva Latest Developments

Table 142. Perrigo Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 143. Perrigo Vaginosis Drug Product Offered

Table 144. Perrigo Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 145. Perrigo Main Business

Table 146. Perrigo Latest Developments

Table 147. West-Ward Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 148. West-Ward Vaginosis Drug Product Offered

Table 149. West-Ward Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 150. West-Ward Main Business

Table 151. West-Ward Latest Developments

Table 152. HPGC Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 153. HPGC Vaginosis Drug Product Offered

Table 154. HPGC Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 155. HPGC Main Business

Table 156. HPGC Latest Developments

Table 157. Yunnan Baiyao Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 158. Yunnan Baiyao Vaginosis Drug Product Offered

Table 159. Yunnan Baiyao Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 160. Yunnan Baiyao Main Business

Table 161. Yunnan Baiyao Latest Developments

Table 162. Starpharma Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 163. Starpharma Vaginosis Drug Product Offered

Table 164. Starpharma Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 165. Starpharma Main Business

Table 166. Starpharma Latest Developments

Table 167. Novel Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 168. Novel Vaginosis Drug Product Offered

Table 169. Novel Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 170. Novel Main Business

Table 171. Novel Latest Developments

Table 172. Edenvridge Basic Information, Vaginosis Drug Manufacturing Base, Sales Area and Its Competitors

Table 173. Edenvridge Vaginosis Drug Product Offered

Table 174. Edenvridge Vaginosis Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 175. Edenvridge Main Business

Table 176. Edenvridge Latest Developments

List of Figures

Figure 1. Picture of Vaginosis Drug

Figure 2. Vaginosis Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vaginosis Drug Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Vaginosis Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vaginosis Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Rx

Figure 10. Product Picture of OTC

Figure 11. Global Vaginosis Drug Sales Market Share by Type in 2021

Figure 12. Global Vaginosis Drug Revenue Market Share by Type (2017-2022)

Figure 13. Vaginosis Drug Consumed in Hospital

Figure 14. Global Vaginosis Drug Market: Hospital (2017-2022) & (K Doses)

Figure 15. Vaginosis Drug Consumed in Pharmacy

Figure 16. Global Vaginosis Drug Market: Pharmacy (2017-2022) & (K Doses)

Figure 17. Vaginosis Drug Consumed in Other

Figure 18. Global Vaginosis Drug Market: Other (2017-2022) & (K Doses)

Figure 19. Global Vaginosis Drug Sales Market Share by Application (2017-2022)

Figure 20. Global Vaginosis Drug Revenue Market Share by Application in 2021

Figure 21. Vaginosis Drug Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Vaginosis Drug Revenue Market Share by Company in 2021

Figure 23. Global Vaginosis Drug Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Vaginosis Drug Revenue Market Share by Geographic Region in 2021

Figure 25. Global Vaginosis Drug Sales Market Share by Region (2017-2022)

Figure 26. Global Vaginosis Drug Revenue Market Share by Country/Region in 2021

Figure 27. Americas Vaginosis Drug Sales 2017-2022 (K Doses)

Figure 28. Americas Vaginosis Drug Revenue 2017-2022 ($ Millions)

Figure 29. APAC Vaginosis Drug Sales 2017-2022 (K Doses)

Figure 30. APAC Vaginosis Drug Revenue 2017-2022 ($ Millions)

Figure 31. Europe Vaginosis Drug Sales 2017-2022 (K Doses)

Figure 32. Europe Vaginosis Drug Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Vaginosis Drug Sales 2017-2022 (K Doses)

Figure 34. Middle East & Africa Vaginosis Drug Revenue 2017-2022 ($ Millions)

Figure 35. Americas Vaginosis Drug Sales Market Share by Country in 2021

Figure 36. Americas Vaginosis Drug Revenue Market Share by Country in 2021

Figure 37. United States Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Vaginosis Drug Sales Market Share by Region in 2021

Figure 42. APAC Vaginosis Drug Revenue Market Share by Regions in 2021

Figure 43. China Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Vaginosis Drug Sales Market Share by Country in 2021

Figure 50. Europe Vaginosis Drug Revenue Market Share by Country in 2021

Figure 51. Germany Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Vaginosis Drug Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Vaginosis Drug Revenue Market Share by Country in 2021

Figure 58. Egypt Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Vaginosis Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Vaginosis Drug in 2021

Figure 64. Manufacturing Process Analysis of Vaginosis Drug

Figure 65. Industry Chain Structure of Vaginosis Drug

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles